GGrantIndex
Sort

326,823 grants matching clinical trial

Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery

$1,636,379
Kirk Seward · Mercator Medsystems, Inc. · R44 · FY2024 · HL

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,636,160
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Physicians' Health Study II: Prevention Trial of Vitamins

$1,636,136
J Michael Gaziano · Brigham And Women'S Hospital · R01 · FY2010 · CA

Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease

$1,636,135
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Data Coordination Center for STEADY-PD3

$1,636,010
Kevin M Biglan · University Of Rochester · U01 · FY2014 · NS

Sex and Age Differences in Immunity to Influenza (SADII)

$1,635,989
Sabra L Klein · Johns Hopkins University · U54 · FY2018 · AG

University of Cincinnati AIDS Clinical Trials Unit- UC ACTU

$1,635,950
Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2011 · AI

Comprehensive dissection of the CLL genome & phenome to improve patient outcomes

$1,635,928
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Immune Responses To AAV-Mediated FIX Gene Transfer

$1,635,904
Wistar Institute · P01 · FY2005 · HL

Phase II Trial of Lonafarnib, Pravastatin and Zoledronic Acid in Progeria

$1,635,620
Mark W Kieran · Dana-Farber Cancer Inst · RC2 · FY2010 · HL

WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT

$1,635,616
David B Clifford · Washington University · U01 · FY2010 · AI

Aurum Clinical Trials Unit

$1,635,530
Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2025 · AI

Role of Viral Reservoirs in the Pathogenesis of HIV Disease

$1,635,322
Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Preclinical Medications Screening in Genetic Models of Alcoholism

$1,635,213
Richard Bell · Trustees Of Indiana University · N01 · FY2011 · HD

Advancement of AEF0117 as a potential treatment for Cannabis Use Disorder: Preclinical toxicity and Clinical pharmacokinetic studies

$1,635,195
Frances Rudnick Levin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U01 · FY2022 · DA

Sex and Age Differences in Immunity to Influenza (SADII)

$1,635,163
Sabra L Klein · Johns Hopkins University · U54 · FY2020 · AG

PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA

$1,635,155
Columbia University Health Sciences · P50 · FY2002 · NS

Inborn Errors of Cholesterol Synthesis

$1,635,106
Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD

Illuminating the Druggable Genome Knowledge Management Center (IDG KMC)

$1,635,000
Tudor I Oprea · University Of New Mexico Health Scis Ctr · U54 · FY2016 · CA

Drug development of RK-33 for breast cancer treatment

$1,634,811
Farhad Vesuna · Natsar Pharmaceuticals, Inc. · R44 · FY2025 · CA

Integrated Genomic and Functional Studies of Tolerance Therapy for Peanut Allerg

$1,634,811
Stephen J Galli · Stanford University · U19 · FY2016 · AI

Integrated Genomic and Functional Studies of Tolerance Therapy for Peanut Allerg

$1,634,811
Stephen J Galli · Stanford University · U19 · FY2013 · AI

Clinical Trials Network, Ohio Valley Node U10DA013732

$1,634,717
Eugene C. Somoza · University Of Cincinnati · U10 · FY2010 · DA

KARABELO Clinical Trials Unit for NIAID Networks

$1,634,670
Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2017 · AI

THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT

$1,634,662
Oklahoma Medical Research Foundation · P50 · FY2003 · HL